Table 1 Baseline patient characteristics, indications and findings
Domperidone | Erythromycin | p | |
|---|---|---|---|
Number of patients | 410 | 239 | |
Male (n,%) | 192 (47) | 108 (45) | 0.69 |
Age, years (median) | 55 (9–93) | 60 (18–89) | 0.03 |
Indications (n,%) | 0.01 | ||
- occult gastro-intestinal bleeding | 253 (62) | 183 (77) | |
- overt gastro-intestinal bleeding | 53 (13) | 20 (8) | |
- suspected Crohn’s disease | 104 (25) | 36 (15) | |
Findings (n,%) | |||
- angiodysplasia(s) | 58 (14) | 57 (24) | |
- erosion(s) | 62 (15) | 14 (6) | |
- ulcera | 25 (6) | 11 (5) | |
- polyp(s)/tumor(s) | 37 (9) | 19 (8) | |
- active bleeding | 22 (5) | 5 (2) | |
- no abnormalities | 206 (50) | 133 (56) |